Method of applying coatings to a medical device

• US 20040059409A1
• Filed: 09/24/2002
• Published: 03/25/2004
• Est. Priority Date: 09/24/2002
• Status: Abandoned Application

• Current Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Scimed (Boston Scientific Corporation)
• Inventors: Stenzel, Eric B.
• Application Number:
  US10/253,603
• Publication Number:
  US 20040059409A1
• Time in Patent Office: Days
• US Class Current: 623/1.15
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/91541 Adjacent bands are arranged out of phase
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2250/0019 differing in hardness, e.g. Vickers, Shore, Brinell
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence

Abstract

A medical device, such as a stent, for delivering a biologically active material to body tissue of a patient and a method of making such a medical device are disclosed. The medical device has a tubular sidewall, wherein the sidewall is comprised of a plurality of struts each having an outer surface, an inner surface opposite the outer surface, and at least one side surface adjacent to and connecting the outer and inner surfaces. The outer surface or the inner surface is covered at least in part with a first coating comprising a first polymeric material and a first coating material, such as a biologically active material, e.g., paclitaxel, paclitaxel analogues, paclitaxel derivatives, or a combination thereof. The outer surface or inner surface not covered with the first coating is covered with a second coating comprising a second polymeric material and that is substantially free of the first coating material. Preferably, the first coating is applied to the outer surface of the strut. The disclosed method allows for greater efficiency and control in applying a biologically active material on the medical device and reduces patient exposure to unnecessary amounts of the biologically active material.

Claims

1. A coated medical device comprising:

a tubular sidewall, wherein the sidewall comprises a plurality of struts each having an outer surface, an inner surface opposite the outer surface, and at least one side surface adjacent to the outer surface and the inner surface and connecting the inner surface and outer surface;

wherein the outer surface or the inner surface has at least a portion that is covered by a first coating comprising a first coating material dispersed in a first polymeric material,

wherein both the side surface and the outer surface or the inner surface, that does not have at least a portion that is covered by the first coating, has at least a portion that is covered by a second coating comprising a second polymeric material and being substantially free of the first coating material,

wherein the first coating and the second coating form a continuous coating disposed on the struts, and

wherein the surface covered with the first coating is substantially free of the second coating and wherein the surface covered with the second coating is substantially free of the first coating.

2. The medical device of claim 1, wherein the tubular sidewall forms a tent.

3. The medical device of claim 1, wherein the first coating material is a biologically active material.

4. The medical device of claim 3, wherein the biologically active material is selected from the group consisting of anti-thrombogenic agents, anti-angiogenesis agents, anti-proliferative agents, growth factors, and radiochemicals.

5. The medical device of claim 4, wherein the anti-proliferative agent is selected from the group consisting of paclitaxel, paclitaxel analogues, paclitaxel derivatives, and combinations thereof.

6. The medical device of claim 1, wherein the first and second polymeric materials are selected from the group consisting of styrene-isobutylene-styrene, polyurethanes, silicones, polyesters, polyolefins, polyisobutylene, ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers, polyvinyl ethers, polyvinylidene halides, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polyvinyl esters, copolymers of vinyl monomers, copolymers of vinyl monomers and olefins, polyamides, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, collagens, chitins, polylactic acid, polyglycolic acid, polylactic acid-polyethylene oxide copolymers, ethylene-propylene-diene rubbers, fluorosilicones, polyethylene glycol, polysaccharides, phospholipids, and combinations thereof.

7. The medical device of claim 1, wherein the second polymeric material is the same as the first polymeric material.

8. The medical device of claim 1, wherein the inner surface is covered by the second coating and the second polymeric material is harder than the first polymeric material.

9. The medical device of claim 1, wherein the first and the second polymeric material are biocompatible.

10. The medical device of claim 1, wherein at least one of said coatings is biodegradable.

11. An expandable stent comprising:

a tubular sidewall, wherein the sidewall comprises a plurality of struts each having an outer surface that is adapted for exposure to a body lumen, an inner surface opposite the outer surface, and at least one side surface adjacent to the outer surface and the inner surface and connecting the inner surface and the outer surface; and

wherein at least a portion of the outer surface is covered by a first coating comprising a biologically active material dispersed in a first polymeric material, wherein the biologically active material is selected from the group consisting of paclitaxel, paclitaxel analogues, paclitaxel derivatives, and combinations thereof; and

wherein at least a portion of the inner surface and side surface is covered by a second coating comprising a second polymeric material and the inner surface and side surface are substantially free of the biologically active material, and

wherein the first coating and the second coating form a continuous coating disposed on the struts.

12. A method of coating a medical device comprising:

(a) providing a prefabricated medical device having a tubular sidewall, wherein the sidewall comprises a plurality of struts each having an outer surface, an inner surface opposite the outer surface, and at least one side surface adjacent to the inner surface and the outer surface and connecting the inner surface and outer surface;

(b) applying to the outer surface or the inner surface a first coating comprising a first coating material dispersed in a first polymeric material; and

(c) applying to either the outer surface or the inner surface, that is not covered by the first coating, and side surfaces a second coating comprising a second polymeric material, wherein the second coating is substantially free of the first coating material material, in a manner such that the first coating and second coating form a continuous coating disposed on the struts and such that the surface covered with the first coating is substantially free of the second coating and that the surface covered by the second coating is substantially free of the first coating.

17. The method of claim 12, wherein the first coating material is a biologically active material.

13. The method of 12, wherein the medical device is a stent.

14. The method of 12, further comprising applying the first coating on the outer surface by rolling the medical device on a substrate coated with the first coating.

15. The method of 12, further comprising applying the second coating to the inner surface and the side surface by spray-coating.

16. The method of 12, further comprising masking either the inner or outer surface while a coating is applied to the opposing surface.

18. The method of 17, wherein the first coating material is a biologically active material is selected from the group consisting of anti-thrombogenic agents, anti-angiogenesis agents, anti-proliferative agents, growth factors, and radiochemicals.

19. The method of claim 18, wherein the anti-proliferative agent is selected from the group consisting of paclitaxel, paclitaxel analogues, paclitaxel derivatives, and combinations thereof.

20. The method of 12, wherein the first and second polymeric materials are selected from the group consisting of styrene-isobutylene-styrene, polyurethanes, silicones, polyesters, polyolefins, polyisobutylene, ethylene-alphaolefin copolymers, acrylic polymers and copolymers, vinyl halide polymers, polyvinyl ethers, polyvinylidene halides, polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics, polyvinyl esters, copolymers of vinyl monomers, copolymers of vinyl monomers and olefins, polyamides, alkyd resins, polycarbonates, polyoxymethylenes, polyimides, polyethers, epoxy resins, polyurethanes, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, carboxymethyl cellulose, collagens, chitins, polylactic acid, polyglycolic acid, polylactic acid-polyethylene oxide copolymers, ethylene-propylene-diene rubbers, fluorosilicones, polyethylene glycol, polysaccharides, phospholipids, and combinations thereof.

21. The method of 12, wherein the first and second polymeric materials are biocompatible.

22. The method of 12, wherein the second polymeric material is the same as the first polymeric material.

23. The method of 12, wherein the inner surface is covered by the second coating and the second polymeric material is harder than the first polymeric material.

24. A method of coating an expandable stent having a sidewall comprising a plurality of struts, each having an outer surface, an inner surface opposite the outer surface, and at least one side surface adjacent to the outer surface and the inner surface and connecting the outer surface and the inner surface, the method comprising:

(a) applying to the outer surface a first coating comprising a biologically active material dispersed in a first polymeric material, wherein the biologically active material is selected from the group consisting of paclitaxel, paclitaxel analogues, paclitaxel derivatives, and combinations thereof; and

(b) applying to the inner surface and the side surface a second coating comprising a second polymeric material in a manner such that the first coating and the second coating form a continuous coating disposed on the struts and the inner surface and side surface are substantially free of the biologically active material.